Influenza Vaccine Effectiveness Against Mild and Severe Outcomes: A Comparison Study in Portugal
This study aimed to compare IVE against mild and severe influenza within primary care and hospital networks in Portugal from 2015/16 to 2023/24.
AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
We have 3 of 155 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
This study aimed to compare IVE against mild and severe influenza within primary care and hospital networks in Portugal from 2015/16 to 2023/24.
Adapted XBB.1.1.5 vaccine provided moderate protection within 120 days after vaccination against severe COVID-19 outcomes among ICPs aged ≥18 years during a period with BA.2.1 replacing the XBB.1.5 variant.
The 2023 and 2024 autumn vaccination campaigns resulted in substantially different numbers of averted COVID-19-related hospitalisations and deaths among older adults, with fewer events averted in 2024, highlighting the impact of vaccination programmes depends not only on VC and VE but also on alignment between vaccinat...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.